Share

Debrecen University Acquires World-Class CT Scanner


A new, high-tech CT scanner at the University of Debrecen can be used to image the human heart as a complex organ, detect tumor lesions in the brain, and even show the condition of a battery, reports Világgazdaság.

Medical Rental Kft., Euro Lízing Kft., GE Healthcare, and the University of Debrecen are jointly participating in the purchase of a new CT scanner, replacing the much weaker one previously used, said Zoltán Szilvássy, rector of the University of Debrecen. Chancellor Zoltán Bács explained that a decision on whether to purchase the equipment will be made after the seven-year lease.

 The new CT scanner, supported by AI, is a state-of-the-art device that can be upgraded in both hardware and software and is capable of serving many disciplines.

It takes 0.23 seconds to circle the entire body and 0.7 seconds (a single heartbeat) to scan the coronary arteries of the heart.

According to Professor Ervin Berényi, head of the Diagnostic Imaging Clinic, an important feature of the new device is its ability to exclude metals that interfere with both CT and MR imaging. As it uses X-rays of varying energy, it can also isolate individual tissues.

With the associated AI applications, it can also remove calcification that can be detected in vascular wall lesions, meaning it can also perform chemical imaging.

Of course, the CT equipment can be used in any medical field in addition to cardiological diagnostics, but it can also help to examine battery structures.

University researchers are also involved in the further software and hardware development of the new device.

Eight years ago, the University of Debrecen started to realize its vision of building unique R&D capabilities. First, a strategic agreement was established with GE HealthCare, followed by IQVIA. The University became one of the top 20 of the IQVIA’s thousands of drug research clinical sites. This greatly increased the scientific capabilities of the university, as well as boosting revenue.

Their third collaborating partner among global companies was Rosatom, and the fourth was the Beijing Genomic Institute. The latter collaboration resulted in having one of the largest sequencing capacities in Europe. This has a major impact on the fight against nosocomial infections caused by hospital-acquired antibiotic-resistant bacteria, on phage research into the partial replacement of antibiotics, and now on their production. BMW joined the collaborators as a fifth company a few years ago.

GE HealthCare has a diversified relationship with the University of Debrecen.

For instance, their software, developed jointly with the university’s Oncoradiology Clinic, is already in use in ten similar centers around the world.

According to clinic director Árpád Kovács, perhaps the most innovative and exciting area of cooperation is teradiagnostics, i.e. the combination of diagnostics and therapy. The idea is to combine a diagnostic marker with a therapeutic procedure, which can then target a tumor, in this case a brain tumor, with great efficiency.

The nuclear medicine background for this has a long tradition in the clinic, with a collaboration with GE HealthCare and now also participants in a Novartis study. Teranostic solutions for lutein therapy of prostate tumor patients are currently in the clinical trials phase. Professor Kovács said the experience gained in these trials opens up the possibility to be at the forefront of introducing this therapy into the daily routine and to use the experience there.

Related article

University of Debrecen Expands with Advanced Laboratory

University of Debrecen Expands with Advanced Laboratory

The new laboratory will give the engineering students the chance to learn about real industrial processes through the latest technologies.Continue reading

Via Világgazdaság, Featured image: Pixabay





Source link